A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis

A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-Uveitis

NCT00404742 ·Status: COMPLETED ·Phase: PHASE3

A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

NCT00404612 ·Status: COMPLETED ·Phase: PHASE3

Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles

NCT07262437 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant

NCT04340505 ·Status: COMPLETED

Efficacy and Safety of Adalimumab in Patients With Active Uveitis

NCT01138657 ·Status: COMPLETED ·Phase: PHASE3

Intravitreal Ketorolac for Chronic Uveitis: A Investigational Safety Study

NCT01164085 ·Status: COMPLETED ·Phase: PHASE1

Evaluation and Treatment of Patients With Inflammatory Eye Diseases

NCT00006188 ·Status: COMPLETED

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

NCT01090310 ·Status: TERMINATED ·Phase: PHASE3

Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate

NCT01314417 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

NCT01095250 ·Status: TERMINATED ·Phase: PHASE3

Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

NCT00770770 ·Status: TERMINATED ·Phase: PHASE2

BIIB033 In Acute Optic Neuritis (AON)

NCT01721161 ·Status: COMPLETED ·Phase: PHASE2

A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

NCT05590416 ·Status: RECRUITING

Phase II Study to Analyze Sarilumab in Non-Infectious Uveitis

NCT01900431 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Long Term Use of Treatment With AIN457 for Uveitis

NCT01327664 ·Status: WITHDRAWN ·Phase: PHASE3

Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

NCT05003245 ·Status: COMPLETED ·Phase: PHASE3

Microbiome as a ThErapeutic Response Biomarker

NCT04721743 ·Status: WITHDRAWN

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

NCT01103024 ·Status: WITHDRAWN ·Phase: PHASE3

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

NCT00058994 ·Status: COMPLETED ·Phase: PHASE3

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

NCT06431373 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema

NCT00958906 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis

NCT01032915 ·Status: TERMINATED ·Phase: PHASE3

Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis

NCT02706704 ·Status: RECRUITING ·Phase: PHASE2

Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,

NCT01526889 ·Status: COMPLETED ·Phase: PHASE2

Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

NCT00517010 ·Status: COMPLETED ·Phase: EARLY_PHASE1